Ceftizoxime & Sulbactam Injection 1.5 Gm

Ceftizoxime & Sulbactam Injection 1.5 Gm

Product Name :

Voriconazole Injection IP 200 Mg

Available Strength :

200 mg

Packing :

Vial / As per your requirement

Pack Insert/ Leaflet :

Available upon request

Therapeutical Use :

Antifungal

Production Capacity :

Available on request

Description:

What is Ceftizoxime & Sulbactam Injection 1.5 Gm?

Ceftizoxime & Sulbactam Injection 1.5 Gm is a combination antibiotic formulation intended for use against susceptible bacterial infections when supported by the approved product information. Ceftizoxime is a cephalosporin antibiotic, while sulbactam acts as a beta-lactamase inhibitor in certain combinations. The specific composition, approved indications and administration requirements should be confirmed against the product specification.

Uses / Indications

Depending on the approved formulation and susceptibility of the causative bacteria, this antibiotic combination may be used by healthcare professionals for selected bacterial infections.

  • Treatment of susceptible bacterial infections where the combination is appropriate.

  • Use in clinical settings under qualified medical supervision.

  • Selection according to the infection type, bacterial susceptibility and approved prescribing information.

It is not intended for treating viral infections such as the common cold or influenza.

Benefits

  • Combines a cephalosporin antibiotic with a beta-lactamase inhibitor.

  • May support antibacterial treatment when the causative organism is susceptible.

  • Dry powder presentation allows preparation according to the approved product instructions.

  • Suitable for professional healthcare use when prescribed for an appropriate indication.

Side Effects

Possible side effects depend on the formulation, dose and individual patient.

Potential side effects may include:

  • Nausea, vomiting or diarrhoea.

  • Pain or discomfort at the injection site.

  • Skin rash or itching.

  • Changes in liver or kidney-related laboratory results.

Seek urgent medical attention for difficulty breathing, swelling of the face or throat, severe skin reactions or persistent severe diarrhoea. These may indicate a serious reaction.

How Does It Work?

Ceftizoxime works by interfering with bacterial cell-wall synthesis, which helps kill susceptible bacteria. Sulbactam inhibits certain beta-lactamase enzymes that can make some bacteria resistant to beta-lactam antibiotics. The effectiveness of the combination depends on the bacteria involved and the susceptibility profile.

Dosage Guidelines

  • Use only under the supervision of a qualified healthcare professional.

  • Dose and treatment duration depend on the infection, patient factors and approved product information.

  • Preparation, dilution and administration must follow the manufacturer’s approved instructions.

  • Renal function and other relevant clinical factors may need consideration.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

This product may be unsuitable for patients with:

  • A known serious allergy to ceftizoxime, sulbactam or relevant formulation ingredients.

  • A history of severe hypersensitivity to cephalosporins or other beta-lactam antibiotics, unless a clinician determines use is appropriate after assessment.

  • Other contraindications specified in the approved product information.

Drug / Product Interactions

Tell the treating healthcare professional about all medicines being taken, including prescription drugs, non-prescription medicines and supplements. Particular attention may be required for:

  • Other antibiotics or medicines that may affect kidney function.

  • Anticoagulants or medicines requiring monitoring during antibiotic treatment.

  • Any medicine associated with previous allergic reactions.

Potential interactions should be checked against the approved prescribing information.

Safety Advice

  • Administer only by appropriately trained healthcare professionals.

  • Confirm the patient’s allergy history before administration.

  • Monitor for allergic reactions and other adverse effects.

  • Use antibiotics only when clinically indicated.

  • Complete the prescribed course unless the treating clinician advises otherwise.

General Instructions

  • Inspect the vial and packaging before use.

  • Do not use damaged, leaking or visibly compromised packaging.

  • Prepare the injection only as directed in the approved product instructions.

  • Do not use a prepared solution beyond the specified period or outside the stated storage conditions.

  • Dispose of unused product and medical materials according to applicable healthcare procedures.

Special Dietary / Lifestyle Tips

No specific dietary plan is established for every patient using this antibiotic combination. Follow the treating healthcare professional’s advice, maintain adequate hydration where medically appropriate, and report persistent gastrointestinal symptoms or other unexpected reactions.

Comparison with Other Treatments

Ceftizoxime & Sulbactam Injection differs from single-agent antibiotics and other antibiotic combinations in its active ingredients and potential antibacterial coverage. The appropriate treatment depends on the infection, culture and susceptibility results when available, patient-specific factors and local prescribing guidance. It should not be assumed to be interchangeable with other antibiotic injections.

Precautions & Warnings

  • Confirm the exact composition and component strengths against the approved product specification.

  • Use cautiously in patients with a history of beta-lactam allergy.

  • Patients with impaired kidney function may require clinical assessment and dosage adjustment.

  • Antibiotic use can contribute to antimicrobial resistance when inappropriate or unnecessary.

  • Severe or persistent diarrhoea during or after treatment requires medical assessment.

  • Use during pregnancy or breastfeeding should be assessed by a qualified healthcare professional.

  • Do not use without a valid clinical indication and professional supervision.

Can I Use It With Other Medicines?

Other medicines may be used alongside this injection only when the treating healthcare professional determines that the combination is appropriate. Provide a complete medication history before treatment. Do not start, stop or change other medicines without professional advice.

Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions. Follow the stated instructions for reconstituted solutions and protect the vial from conditions prohibited by the approved labelling.

Frequently Asked Questions

1. What is Ceftizoxime & Sulbactam Injection 1.5 Gm used for?

It may be used for selected susceptible bacterial infections when indicated by the approved product information and prescribed by a healthcare professional.

2. What is the role of sulbactam in this combination?

Sulbactam inhibits certain beta-lactamase enzymes, which may help protect susceptible beta-lactam antibiotics from enzymatic breakdown.

3. Is this injection effective against viral infections?

No. Antibiotics do not treat viral infections such as influenza or the common cold.

4. Who should administer this injection?

It should be prepared and administered by a qualified healthcare professional according to the approved instructions.

5. Can the injection be used in patients with kidney problems?

Patients with kidney impairment need clinical assessment because kidney function may affect antibiotic dosing and monitoring.

6. Can it cause an allergic reaction?

Yes. Allergic reactions are possible. Patients should disclose any previous antibiotic allergies before treatment and seek urgent care for symptoms of a severe reaction.

7. How should the injection be stored?

Follow the manufacturer’s approved storage instructions printed on the packaging or supplied with the product.

8. Is the 1.5 Gm strength sufficient to determine the exact dose?

No. The total stated strength alone does not determine an individual patient’s dose. The component strengths, indication and approved prescribing information must be confirmed.

Scroll to Top